OCGN - Ocugen, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
42.62
0
Operating expenses
Research development
49,757
49,757
35,108
6,353
8,086
Selling general and administrative
35,111
35,111
22,920
7,974
6,077
Total operating expenses
84,868
84,868
58,028
14,327
14,163
Operating income or loss
-84,868
-84,868
-58,028
-14,285
-14,163
Interest expense
-
-
79
720.963
1,768
Total other income/expenses net
3,517
3,517
-310
-6,817
-4,313
Income before tax
-81,351
-81,351
-58,417
-21,822
-20,243
Income tax expense
0
0
-52
-
-
Income from continuing operations
-81,351
-81,351
-58,365
-21,822
-20,243
Net income
-81,351
-81,351
-58,365
-21,822
-20,243
Net income available to common shareholders
-81,351
-81,351
-58,365
-34,368
-20,243
Basic EPS
-
-
-0.30
-0.31
-1.46
Diluted EPS
-
-
-0.30
-0.31
-1.46
Basic average shares
-
-
195,013
112,236
13,894
Diluted average shares
-
-
195,013
112,236
13,894
EBITDA
-
-84,868
-58,338
-21,101
-18,414